Benmelstobart: clinical trials recruiting now

3

Recruiting trials

12

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 3

Conditions being studied

Condition	Trials
Breast Cancer	2
Breast Neoplasm	1
Breast Tumors	1
Early-stage Breast Cancer	1
HER2-negative Breast Cancer	1
HER2-positive Breast Cancer	1
Hormone Receptor Negative Tumor	1
Hormone Receptor Positive Tumor	1
Locally Advanced Breast Cancer	1
Lung cancer	1
Non-Small Cell Lung Cancer	1
Triple-Negative Breast Cancer (TNBC)	1

Recruiting trials involving Benmelstobart

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
NCT06528847 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 1 location
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
NCT06992336 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many recruiting trials involve Benmelstobart?

3 recruiting trials across 12 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.